Clinical trial
Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist
NCT01440049 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- December 31, 2010
- Enrollment
- 160 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular dysfunction post myocardial infarction